ADIPOQ and Abdominal obesity: Abdominal obesity, a key component of MetS, is consistently associated with major increases in pro-inflammatory adipocytokines, such as TNF-α, IL-6, hsCRP or PAI-1 active, as well as reduced protective cytokines, such as adiponectin, agreeing with our data [42]-[44].